Arabesque Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,448
Closed -$1.08M 121
2022
Q2
$1.08M Sell
14,448
-704
-5% -$64.3K 0.57% 89
2022
Q1
$1.94M Hold
15,152
0.67% 75
2021
Q4
$2.03M Buy
15,152
+100
+0.7% +$14.4K 0.59% 84
2021
Q3
$2.06M Buy
+15,052
New +$1.9M 0.69% 64
2020
Q3
Sell
-33,528
Closed -$3.4M 75
2020
Q2
$3.4M Buy
+33,528
New +$3M 2.3% 9
2020
Q1
Sell
-41,996
Closed -$2.3M 64
2019
Q4
$2.3M Buy
+41,996
New +$1.99M 0.88% 52

Other funds holding DXCM

Arabesque Asset Management's DXCM Position: Q3 2022 in Review

Arabesque Asset Management sold out of DexCom (DXCM) in Q3 2022, closing a stake of 14,448 shares — an estimated $1.08M sold.

Arabesque Asset Management first reported a position in DXCM in Q4 2019 and held it in 6 quarters. The position peaked at $3.4M in Q2 2020. 795 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

  • Arabesque Asset Management reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
  • Arabesque Asset Management sold 14,448 DexCom shares in Q3 2022, an estimated $1.08M.
  • Arabesque Asset Management first reported a position in DexCom in Q4 2019 and held it in 6 quarters.
  • Arabesque Asset Management's DexCom position peaked at $3.4M in Q2 2020.
  • 795 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Arabesque Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.